i****f
发帖数: 473 | 1 Exubera
first alternative to insulin injection - it's inhalable now.
estimated 1.1 billion in sales by 2010
Sutent
multiple kinase inhibitor
kidney and stomach cancer |
a*y
发帖数: 119 | 2 that is OK, since so many chemotherpeutic drug used in clinical are very toxic
too.
BTW, Sutent is for patients with progressed gastrointestinal stromal tumors.
Patients will be desperate to try any effective drug no matter how many side
effects there will be |
k**a
发帖数: 284 | 3 那倒是,不过它的target也太多了
【在 a*y 的大作中提到】
: that is OK, since so many chemotherpeutic drug used in clinical are very toxic
: too.
: BTW, Sutent is for patients with progressed gastrointestinal stromal tumors.
: Patients will be desperate to try any effective drug no matter how many side
: effects there will be
|
a*y
发帖数: 119 | 4 it is for cancer therapy, anyway
【在 k**a 的大作中提到】
: 那倒是,不过它的target也太多了
|
k**a
发帖数: 284 | 5 那倒是,不过它的target也太多了
【在 a*y 的大作中提到】
: it is for cancer therapy, anyway
|
a*y
发帖数: 119 | 6 I think Exubra will have problem in a few years, sigh
【在 i****f 的大作中提到】
: Exubera
: first alternative to insulin injection - it's inhalable now.
: estimated 1.1 billion in sales by 2010
: Sutent
: multiple kinase inhibitor
: kidney and stomach cancer
|
k********u
发帖数: 69 | 7 that's so true.
toxic
【在 a*y 的大作中提到】
: that is OK, since so many chemotherpeutic drug used in clinical are very toxic
: too.
: BTW, Sutent is for patients with progressed gastrointestinal stromal tumors.
: Patients will be desperate to try any effective drug no matter how many side
: effects there will be
|
a**l
发帖数: 14 | 8 The wall street estimate of $1.1B is fairly pessimistic. This product can
really change patient's life. I think Exubera will be a blockbuster and can
achieve more than $2 billion after 2010. That is why Pfizer spent $1.5B to
buy exclusive right to the drug due to its huge potential. $1.1B in the
pharma world was almost nothing and does not worth the money Pfizer already
throw in the pot.
I believe this product will achive sub-lipitor publicity/status given the
talents and genius of the Pfize
【在 i****f 的大作中提到】
: Exubera
: first alternative to insulin injection - it's inhalable now.
: estimated 1.1 billion in sales by 2010
: Sutent
: multiple kinase inhibitor
: kidney and stomach cancer
|
c****m
发帖数: 67 | 9 卖药全靠吹出来的.
【在 i****f 的大作中提到】
: Exubera
: first alternative to insulin injection - it's inhalable now.
: estimated 1.1 billion in sales by 2010
: Sutent
: multiple kinase inhibitor
: kidney and stomach cancer
|
b*******e
发帖数: 724 | 10 Not necessarily! Liptor fetched $10 bil for Pfizer last year. Why no other
Chlestrol lowering drugs can even come close to half of Liptor's sales?
Pfizer's marketing force is good, but not twice as good.
【在 c****m 的大作中提到】
: 卖药全靠吹出来的.
|
